biotech group alexion in a $30 billion u.s. cash disease.e takeover comes after activist investor eliot management pressured alexion to sell itself back in may. so this is a huge deal in the pharmaceutical space, a huge deal for astrazeneca. from a strategic point of view, analysts are focusing on two aspects here. one, the financial implications of this deal, and two, what this means for astrazeneca's portfolio. from a financial point of view, the bulls on astrazeneca are pointing to the fact that this will accelerate the company's cash generation profile, improve their near-term cash generation, and from a portfolio perspective, this will deepen astrazeneca's planned expansion into immunology. so they are viewing this in a positive light. from a dividend perspective, it could potentially add a sweetener with astrazeneca, saying they plan to delever very, very quickly and are considering increasing their dividend as a result. so the analyst community here in new york seems to like this deal, by and large, from an astrazeneca perspective. >>

alexion shares, they were up 32%. inres were slumping astrazeneca after the $39 million deal for alexion. coming up, thee rollout of vaccine and what it means for investments and markets in 2021. that is next, and this is bloomberg. ♪ >> economics, finance, and politics. this is "bloomberg: surveillance ." i'm francine lacqua in london. breaking news out of singapore, the most encouraging story in thatast couple of weeks, vaccines are being rolled out, a lot of countries have access. on the flipside, countries having to go into more lockdown measures because of concerns cases arising. singapore has approved its pfizer vaccine, arriving by the end of the year and they also put encouraging statement out saying they should have enough vaccine for the whole population by the third quarter of next year. in the u.s., hospitals are preparing to receive the first shipments of the coronavirus vaccine from pfizer. health care workers and nursing home residents will be prioritized. cases are surging in the u.s., with deaths reac

after the reformation referendum in 2016 but now we have the ramifications of the 2020 alexion in the united states now coming up into the election and actually ever since the trump brand president and to that they 2016 campaign there's been this hot of a cultural civil war in the united states and it's actually very real it's very rare culturally here now as a result of this election here it's a bizarre election i will leave it at that it is rekindled a lot of very strong. passions among people in the united states and we used the. terms of red and blue here and those those tensions are only simmering here particularly when you have the media and the professional elites all on one side and then you have these people that were supporters of donald trump donald trump got 10 more 1000000 votes than he did 4 years ago though somehow he lost the election here passions are very very high markets and sometimes you can't unring bells if you know what i mean go ahead festival i want to clarify something for the people who are sharing. the agenda in america which is culturally divisive and cul

as you mentioned alexion pharmaceuticals is a rare disease company.hey have a blood disease treatment that is a big portion of their revenue, about 60 percent of their revenue, so that is likely what astrazeneca is targeting. that treatment does come off patent five years. you have five years of this blockbuster drug. and it is a bit of a move into a new space for astrazeneca. astrazeneca's revenue breakdown. the bulk of their revenue is oncology, then cardiology. so rare diseases will be a new area to broaden them. as for the shares of alexion pharmaceuticals on the year, of course it has been a big year for pharmaceutical stocks, not so much for them. you see them turning in the right direction, but not as much. but today, 40 5% up on the year. pretty impressive now that we have this deal announced, this buyout. amanda: and it stands out. astrazeneca has a lot on its late. give us some context around m&a. has there been much of it? a lot on their plate in terms of the cancer drugs, but also of course the vaccine raise. as for this year -- >> as for

and astrazeneca is buying alexion in the highest deal ever. the move would boost astrazeneca's footprint in treating rare diseases. you can see alexion shares up 35%, astrazeneca down roughly 5%. back to the overall markets, the major averages ending lower and snapping a winning streak in the first full week of december. while investors are growing optimistic about vaccines several concerns continue, including discussions in d.c. and brexit talks. for more now we are joined by candace bankson, on the team at fiera capital. is a worrisome fact that we are at record highs despite the unknowns in play? >> absolute lit. there are a lot of near risks and headlines that are worrisome, whether it's the brexit deliberations. delays on the fiscal front in the u.s. and the latest worrisome virus trends across the u.s. and europe. and, of course, the potential for some near term economic impacts. but our sense is that given these vaccine break throughs, investors will be able to work through some of the near term headline risks towards a more lucrative 2

i mean, we've seen a couple of transactions this week astrazeneca buying alexion, you know yesterday eli lilly made a small transaction in the space we think this will keep up there's really no reason not to. i think all of the pharmaceutical companies and large cap basically, you know, suffer from, you know, similar consequences which is the larger they get and the larger their drugs become, the more significant the loss of exclusivity on key major branded products becomes and it's almost a circular reference in terms of their need to go out and find targets that will enable them to grow again, so m & a - i would venture to guess that 2021 is going to be very active here again. >> yeah, but bottom line, you think this -- this whole sector can do well, even if there's profit-taking in moderna and the other vaccine names because they are big components >> definitely. i mean, that's been -- that's been the sort of -- the shakeiest ground in this entire index has been the vaccine stocks and a their weightings and how to look at sort of the xbi components, you know, i respective of what'

astrazeneca's stock price might not be quite worth that but you can see shares of alexion are up andntering a definitive agreement in which astrazeneca will be buying alexi ooon. american depository shares and, again, we will keep an eye on those because they did appear to be down as much as 6%. no real overlap between these two companies. i'm told by the way that they did begin speaking in the summer. let's call it late summer of this year. and that the approach was made by astrazeneca and, clearly, they made a lot of progress. now, could there be another bidder some would say because perhaps the premium not as large as some might have anticipated. seems unlikely. doesn't appear a competitive process in any real way but at the same time, jim, you're talking about astrazeneca which is more highly valued than the companies it competes against and to compare that in conjunk wi in cash. a $6 billion revenue company, obviously had important therapies and rare disease and chief one amongst them is the antibody that is used in a number of different treatments. >> you have to hope the pipel

schlink in venice while his capital caracas good to see you most of the venezuelan opposition say this alexion as a fosse and are boycotting up with that in mind what is really at stake for the country well there probably is not much work hasn't already been lost there's no credibility in the electoral system most people don't feel represented by the term used by the opposition and the humanitarian crisis is only open then it has taken a toll on society most people here are more worried about how they're going to feed themselves during christmas then on the elections so it has been easy to force people to vote. for them food or what's worse by threatening to take government in front of them if they don't so there is a strong grip on society as the president and people are more dependent on the government setting the opposition our congress just makes things easier for men who are to use that branch of the government and the status quo despite what they do with one of the european union is to say a parliament was the last officially opposition controlled government institution in the country ev

public is that we know better than you do and that it's no it's no surprise that during the g 2020 alexion foreign policy was hardly discussed whatsoever here so again we have this kind of separation between what they manage royal professional clowns believes should be done and what the public wants the public is against these wars here and if george is right and unfortunately he probably is right we have more we have the same old wars continuing and possibly some new ones and we after 3 presidential election cycles in a row ever is consistently these conflicts are on wanted they're not popular with the public and that was the reason why i'm bringing that up because then and 2024 you know that there's going to be a candidate out there and say i told you so they will never end these wars. there if the democrats are giving this individual a gift go ahead max right well i think all it is a president proponents of greater cooperation is that the united states and russia in an ideal world i can name the tons of issue where moscow and washington could generally cop rate unfortunately that's not

geographic divides in the country a lot of instability a lot of distrust but it appears that the 2020 alexion is wrapping up joe biden is the winner and despite donald trump's refusal to accept the results it appears that joe biden will be sworn in this january i cannot thank you for that report that's been in new york. parts of france now where hospitality workers have gathered in paris against prolonged lockdown measures which they say are crippling their industry although some restrictions were lifted on tuesday restaurants bars and cafes will have to stay shuts right across the holidays until the 20th of january they say it's threatening not only their livelihoods but also as they put it the french way of life earlier my colleague andrew farmer discusses with this with r.t. is that a solid to the ski who was out there processed. a lot. of individuals from a number of different sectors the restaurant cafe impost sector but also from the tourism sector too in those people who own entertainment venues like. venues both come out to tell the government they want to open up their business becau

checking thing this is the witnesses all of that has been thrown out of the window and in the 2020 alexion so when he said that what i'd like to see an accurate result princes' i want to see the signature matching on that they can i mean that's a that's a something as well and reasonable about that i mean how can you have mainly in voting without actually checking the signatures of the people who are sending in the votes now trump says that he represents 74000000 people and that he represents all of the people that didn't vote for him well what realistic options does he have left i mean 80000000 people voted for joe biden what real list of options does he have it sounds like that he's trying to appeal to all bases now. well i think he's going to try what he can between now and january the 20th i think that. if he fails at all of the court challenges i mean he may go the. the route of trying to appeal to the electors. so that the the state legislators don't certify the electors and then the house of representatives also doesn't sort of by the college of electors i don't think that's likely

months of parliamentary wrangling failed to secure a new budget the country is now heading for its 4th alexion in 2 years told a quarter to coast through the story really seems like tuesday's budget roadblock was the last straw for israel's 7 month long ruling government coalition now benjamin netanyahu party and benny gantz is blue and white party are both blaming one another for the impasse and with these new elections scheduled for march i think we could possibly be seeing the end to 11 years of the premiership of benjamin netanyahu but netanyahu doesn't seem very worried. when i'm not afraid of elections we are prepared for that we will win the public in israel knows who's bringing in millions of vaccines for peace agreements who's blocking iran who is bringing security and who will restore the economy with great impetus. well netanyahu is ratings are actually at an all time low but he's still projected to do better than dance in these new snap elections but he polls are actually saying these not projected to win a majority like in these previous instances i mean after all his political ca

promoted them right now what we see is that you tube has declared itself the arbiter of the 2020 alexion even though there are still active court cases going on in the supreme court challenging results so it's if you're really anywhere not just the us this should scare you we do not want an elected officials like the people who work at youtube and at google deciding what we can and cannot say in regard to politics slowly but surely we've seen tech companies like you tube but facebook and twitter as well start to exert more control and more censoring of what their users say this is concerning this is absolutely a threat to free speech and if you're someone who believes that you should be able to say whatever opinions you want then you need to look at this seriously because yes these are private companies but at the same time the way the public discourse has evolved a century these online platforms function as the public square. so let's return to our top story and that is the u.s. government advisory panel giving the green light to the code vaccine that after a vote was held on whether th

barr a donald trump appointee has said that there is no evidence of widespread fraud in the 2020 alexion and certainly nothing that would result in overturning of the election so donald trump continues to push the idea that there was widespread fraud with no evidence to back that up he's been tweeting it and just in the last couple of hours. and bear in mind that rudy giuliani his attorney has said that he will continue his legal battle all the way up to 11 59 am on the 28th of january just a minute before joe biden will take the oath of office is the 46 president of the united states so it's hard to believe that even after the electoral college votes donald trump will see you know what i have lost the election that he will give it up at this point he is going to continue to push and push all the way to inauguration day and probably even beyond here probably so i'll end faithless voters are not neal i mean we've seen them obviously in past elections but we are seeing now is that some states have actually put extra security in for the vote how how strange or unprecedented is that. well ju

happening today the electoral college certify the results of the 2020 alexion affirming president elect joe biden and. vice president elect harris but with those massive violent protests taking place over the weekend. things are getting pretty sticky and even more is expected to take place today lawmakers in michigan were even forced to use a security escort as they made their way in to make their vote this morning joining us now to discuss all the latest developments here's our tease rachel blevins. oh right always a pleasure having you over to thank you very astutely well rachel can you just give us a rundown of these protrude rallies and why are people still showing up i mean the race of the society we know how it ended it ended weeks ago technically. news every request to try to change the results these rallies are still happening across the united states not just in d.c. why yes oh this latest rally here in d.c. was referred to as the 1000000 magen march say about 3 times fast this is a segment on the we've seen here in d.c. and then even across the country we've seen these quote u

the move on seneca will be $39hing on the ftse, billion deal for alexion.ghing on share prices. elsewhere in london, we do see optimism around the brexit talks, michel barnier saying he can see a way to a deal. as result of that noise, moving higher the domestically focused banks. delivery hero moving to the upside on the back of germany going to a much tougher lockdown for just under a month, it would seem, at least. that will be dish -- introduced on month day -- on wednesday. matt: u.s. lawmakers are pushing nine put a billion-dollar coronavirus pandemic -- 9.8 billion-dollar coronavirus pandemic relief. death remain over whether congress will pass it. hard-fought negotiations will produce results. of course, there's a completing billion package from steven mnuchin. bob is still with us. do we assume some kind of basically trillion dollar package goes through now, and then president biden starts working on more relief after january? week's pritikin rickel -- pretty critical. they extended the debt ceiling. that needs to be extended further unless that do

feed then that seems unlikely he himself is still saying that there was widespread fraud in the 2020 alexion he said there is great evidence coming and you have to remember that of course the don't trump was the man who said that there was great evidence coming in that barack obama was not born in the united states and then just before the election 4 years ago had to stand up and say that he was wrong and actually barack obama was so when he talks about great evidence coming in we're never entirely sure this just don't trump going being a bit overly optimistic or whether there's actually evidence arriving but certainly we've seen nothing to this point that suggests there was widespread fraud and just a reminder donald trump has lost more than 50 court cases across the united states but he's still keeping his focus on january the 6th that's when there will be a joint session of congress to ratify the decision of the electoral college he is hoping that there will be a number of republican politicians who will say that they do not ratify that decision but there simply won't be enough of them to

over the weekend, news of the acquisition of the alexion, the rare disease company out of the uniteds. astrazeneca continues with shareholders, not sure if they are just concerned about the nature of the target, but nevertheless this news has not been greeted while. it's down. 's up by 1.98%. a suggestion that may be now, as they look at options for reebok, which has always been a tough fit for adidas, there may be options including the possible sale of that business. the market is liking that news, up by nearly 2%. alix: do you say reebok differently? guy: just add a dos. -- just adidas. alix: tech in the u.s., up by 1% on the nasdaq. the european union is set to unveil sweeping tech regulations tomorrow. they could face fines of 10% of their annual revenue there. bannempanies will also be d from using data to favor their own services in the search rankings. natalia is with us now. talk us through what we know that could be in this. natalia: yes, there are two sets of rules that will be proposed tomorrow and both of them could basically hit the big tech giants with fines. the first

plus, astrazeneca lands a $39 billion megadeal to take over alexion pharmaceuticals. it's the company's biggest deal since it was founded. good morning, everyone, and welcome to "bloomberg surveillance." i'm francine lacqua in london. lisa abramowicz in new york. tom keene off, chopping a tree or something like that. is a lot to talk about. and kind of tired of brexit. i know most of the people watching are tired of brexit, but it is the final stretch, and i want to remind everyone, december 31 is not a moving deadline. they should not be able to go over. lisa: which is key. jon ferro, my colleague, is always talking about, what does the deadline mean if they keep getting pushed back? yet we are getting to a hard stop, so any progress is key at this point to prevent a hard brexit. francine: so we will look at brexit, we will talk about astrazeneca, and that little thing called stimulus in the u.s. let's get to first word news with karina mitchell. karina: hospitals in the u.s. will start getting the coronavirus vaccine today. shipments started leaving pfizer's michiga

astrazeneca says its purchase of alexion will put it in the top of the ftse index in london. sunday times the deal will help their work in immunology and offers a good chance of it becoming the most valuable company on the london stock exchange. some question the logic of the $39 billion deal, but it does not really seem to sit with their current focus. abu dhabi's national energy company is planning to buy fuel distribution assets in saudi arabia as it expands across the region. it is not releasing any details of what it may target, but already has two outlets in the kingdom as well as india and egypt. in february, they said they would set aside at least half $1 billion to fund a new gas station delivery program from this year. coming up, we have got our conversation with the singapore prime minister about the shifting role of the u.s. in asia under a joe biden presidency. this is bloomberg. ♪ ♪ ties between the u.s. and china have sunk under the trump administration, with tensions rising over trade, human rights, and the coronavirus pandemic. so will it be any different whe

pharmaceutical deal, astrazeneca shares are down to an eight month low after it agreed to you acquire alexion $39 billion in cash and stock. that would be the u.k. pharma giant's biggest deal ever. your reaction to what's going on this morning with the vaccine as well as a handful of deals. >> yeah, hey, this astrazeneca deal i think is very good for astrazeneca. it's a 45% premium they're paying and that's really not high by this industry's standards. i wouldn't be surprised, maria, to see other bids be elliy listy this agreement. rare disease drug makers is a lucrative business. you can make a lot of money from it by selling it to a small group, subset of the population. this is what a lot of big pharma companies, maria, have done to produce or boost sales growth and from what i was looking at the numbers over the weekend, maria, this is going to be a very big sales boost for astrazeneca. i think over the long term this is going to be a profitable business for them and acquisition. maria: yeah. a lexion shares up better than 30% right now. that's not the only of deal we're talking about. a

a little bit of deal news today, astrazeneca buying alexion pharmaceuticals.est deal done, $175 a share. a 40% premium over the average price in the last month alone. the move will boost astrazeneca's footprint in treating rare diseases. >>> when we come back we'll discuss hackers (harold) twelve hundred strings of lights. (betsy) quarter mile of tinsel. (harold) and real snow all the way from switzerland. (betsy) hmmhm... gonna be tough to top. well played. (vo) add some thrill to your wish list. at the season of audi sales event. get exceptional offers now. (vo) verizon 5g is here. with the coverage of 5g nationwide and the unprecedented performance of ultra wideband in more and more places where people need massive capacity and ultra-low lag. this is the 5g america's been waiting for. only from verizon. but with the covid-19 crisis, many veterans are struggling - to make ends meet or get the care they need. dav has helped ill and injured veterans for one hundred years, but today, the need is greater than ever. give to the dav covid-19 relief fund - and help